Literature DB >> 18533622

Prevention of shockwave induced functional and morphological alterations: an overview.

Kemal Sarica1, Faruk Yencilek.   

Abstract

Experimental as well as clinical findings reported in the literature suggest that treatment with shock wave lithotripsy (SWL) causes renal parenchymal damage mainly by generating free radicals through ischaemia/reperfusion injury mechanism. Although SWL-induced renal damage is well tolerated in the majority of healthy cases with no permanent functional and/or morphologic side effects, a subset of patients with certain risk factors requires close attention on this aspect among which the ones with pre-existing renal disorders, urinary tract infection, previous lithotripsy history and solitary kidneys could be mentioned. It is clear that in such patients lowering the number of shock waves (per session) could be beneficial and has been applied by the physicians as the first practical step of diminishing SWL induced parenchymal damage. On the other hand, taking the injurious effects of high energy shock wave (HESW) induced free radical formation on renal parenchyma and subsequent histopathologic alterations into account, physicians searched for some protective agents in an attempt to prevent or at least to limit the extent of the functional as well as the morphologic alterations. Among these agents calcium channel blocking agents (verapamil and nifedipine), antioxidant agents (allopurinol, vitamin E and selenium) and potassium citrate have been used to minimize these adverse effects. Additionally, therapeutic application of these agents on reducing stone recurrence particularly after SWL will gain more importance in the future in order to limit new stone formation in these cases. Lastly, as experimental and clinical studies have demonstrated, combination of anti-oxidants with free radical scavengers may provide superior renal protection against shock wave induced trauma. However, we believe that further investigations are certainly needed to determine the dose-response relationship between the damaging effects of SWL application and the protective role of these agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18533622

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  13 in total

1.  Evaluating ESWL-induced renal injury based on urinary TNF-α, IL-1α, and IL-6 levels.

Authors:  Cemal Goktas; Abdurrahman Coskun; Zerrin Bicik; Rahim Horuz; Ibrahim Unsal; Mustafa Serteser; Selami Albayrak; Kemal Sarıca
Journal:  Urol Res       Date:  2012-10

Review 2.  Aspects on how extracorporeal shockwave lithotripsy should be carried out in order to be maximally effective.

Authors:  Hans-Göran Tiselius; Christian G Chaussy
Journal:  Urol Res       Date:  2012-06-27

3.  Development of a novel magnetic resonance imaging acquisition and analysis workflow for the quantification of shock wave lithotripsy-induced renal hemorrhagic injury.

Authors:  Rajash K Handa; Paul R Territo; Philip M Blomgren; Scott A Persohn; Chen Lin; Cynthia D Johnson; Lei Jiang; Bret A Connors; Gary D Hutchins
Journal:  Urolithiasis       Date:  2017-01-10       Impact factor: 3.436

Review 4.  Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.

Authors:  Saeed R Khan
Journal:  J Urol       Date:  2012-09-25       Impact factor: 7.450

5.  Optimising an escalating shockwave amplitude treatment strategy to protect the kidney from injury during shockwave lithotripsy.

Authors:  Rajash K Handa; James A McAteer; Bret A Connors; Ziyue Liu; James E Lingeman; Andrew P Evan
Journal:  BJU Int       Date:  2012-05-22       Impact factor: 5.588

6.  A chronic outcome of shock wave lithotripsy is parenchymal fibrosis.

Authors:  Rajash K Handa; Andrew P Evan
Journal:  Urol Res       Date:  2010-07-15

7.  Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats.

Authors:  Mohammad Reza Naghii; Eslam Eskandari; Mahmood Mofid; Mehdi Jafari; Mohammad Hossein Asadi
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

8.  Hyperoxaluria-induced tubular ischemia: the effect of verapamil on the limitation of tissue HIF-1 alpha levels in renal parenchyma.

Authors:  Faruk Yencilek; Kemal Sarica; Bilal Eryildirim; Sakip Erturhan; Metin Karakok; Ugur Kuyumcuoglu
Journal:  Int Urol Nephrol       Date:  2009-07-16       Impact factor: 2.370

9.  Preventive effects of COX-2 inhibitor, celecoxib on renal tubular injury induced by shock wave lithotriptor.

Authors:  Hyoung Keun Park; Hae Won Lee; Kwang Soo Lee; Jong Sun Choi; Byong Chang Jeong; Hyeon Hoe Kim
Journal:  Urol Res       Date:  2009-12-01

Review 10.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.